Sartorius Aktiengesellschaft (0NIQ.L)
EUR 159.0
(1.02%)
EUR 159.0
(1.02%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.56 Billion EUR | -28.65% |
| 2022 | 2.19 Billion EUR | 19.44% |
| 2021 | 1.83 Billion EUR | 52.43% |
| 2020 | 1.2 Billion EUR | 28.19% |
| 2019 | 941.09 Million EUR | 17.11% |
| 2018 | 803.6 Million EUR | 13.69% |
| 2017 | 706.84 Million EUR | 11.88% |
| 2016 | 631.79 Million EUR | 14.51% |
| 2015 | 551.74 Million EUR | 30.51% |
| 2014 | 422.76 Million EUR | 9.92% |
| 2013 | 384.6 Million EUR | -7.53% |
| 2012 | 415.91 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 396.2 Million EUR | 19.66% |
| 2024 Q2 | 388.3 Million EUR | -1.99% |
| 2024 Q3 | 345.1 Million EUR | -11.13% |
| 2023 FY | 1.56 Billion EUR | -28.65% |
| 2023 Q4 | 331.1 Million EUR | -8.0% |
| 2023 Q2 | 406.9 Million EUR | -13.28% |
| 2023 Q1 | 469.2 Million EUR | -17.45% |
| 2023 Q3 | 359.9 Million EUR | -11.55% |
| 2022 Q2 | 533.69 Million EUR | -0.84% |
| 2022 Q1 | 538.2 Million EUR | 12.05% |
| 2022 FY | 2.19 Billion EUR | 19.44% |
| 2022 Q3 | 556.09 Million EUR | 4.2% |
| 2022 Q4 | 568.4 Million EUR | 2.21% |
| 2021 Q2 | 455.4 Million EUR | 8.97% |
| 2021 Q4 | 480.32 Million EUR | -1.23% |
| 2021 FY | 1.83 Billion EUR | 52.43% |
| 2021 Q1 | 417.9 Million EUR | 26.91% |
| 2021 Q3 | 486.3 Million EUR | 6.79% |
| 2020 Q1 | 264.6 Million EUR | 8.04% |
| 2020 Q2 | 284.4 Million EUR | 7.48% |
| 2020 Q3 | 328.6 Million EUR | 15.54% |
| 2020 Q4 | 329.29 Million EUR | 0.21% |
| 2020 FY | 1.2 Billion EUR | 28.19% |
| 2019 Q3 | 237 Million EUR | 0.38% |
| 2019 Q1 | 223.1 Million EUR | 7.72% |
| 2019 FY | 941.09 Million EUR | 17.11% |
| 2019 Q4 | 244.89 Million EUR | 3.33% |
| 2019 Q2 | 236.1 Million EUR | 5.83% |
| 2018 Q2 | 201.5 Million EUR | 6.95% |
| 2018 FY | 803.6 Million EUR | 13.69% |
| 2018 Q4 | 207.1 Million EUR | 0.24% |
| 2018 Q1 | 188.4 Million EUR | 1.16% |
| 2018 Q3 | 206.6 Million EUR | 2.53% |
| 2017 FY | 706.84 Million EUR | 11.88% |
| 2017 Q1 | 170.8 Million EUR | 7.49% |
| 2017 Q2 | 177.4 Million EUR | 3.86% |
| 2017 Q3 | 172.4 Million EUR | -2.82% |
| 2017 Q4 | 186.24 Million EUR | 8.03% |
| 2016 Q2 | 156.2 Million EUR | 4.97% |
| 2016 FY | 631.79 Million EUR | 14.51% |
| 2016 Q4 | 158.89 Million EUR | -5.31% |
| 2016 Q3 | 167.8 Million EUR | 7.43% |
| 2016 Q1 | 148.8 Million EUR | 8.18% |
| 2015 Q3 | 149.3 Million EUR | 6.41% |
| 2015 FY | 551.74 Million EUR | 30.51% |
| 2015 Q2 | 140.3 Million EUR | 11.35% |
| 2015 Q1 | 126 Million EUR | 13.96% |
| 2015 Q4 | 137.54 Million EUR | -7.87% |
| 2014 Q2 | 106.4 Million EUR | 8.57% |
| 2014 Q1 | 98 Million EUR | 58.06% |
| 2014 Q3 | 107.8 Million EUR | 1.32% |
| 2014 Q4 | 110.56 Million EUR | 2.56% |
| 2014 FY | 422.76 Million EUR | 9.92% |
| 2013 Q2 | 113.2 Million EUR | 8.22% |
| 2013 Q1 | 104.6 Million EUR | 1.14% |
| 2013 Q3 | 104.6 Million EUR | -7.6% |
| 2013 Q4 | 62 Million EUR | -40.72% |
| 2013 FY | 384.6 Million EUR | -7.53% |
| 2012 FY | 415.91 Million EUR | 0.0% |
| 2012 Q4 | 103.41 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Cegedim SA | 39.99 Million EUR | -3818.534% |
| Guerbet SA | 589.46 Million EUR | -165.851% |
| Nexus AG | 65.97 Million EUR | -2275.33% |
| Bastide Le Confort Médical SA | 46.83 Million EUR | -3246.216% |
| Revenio Group Oyj | 45.27 Million EUR | -3361.216% |
| Drägerwerk AG & Co. KGaA | 1.45 Billion EUR | -7.358% |
| LNA Santé SA | 82.71 Million EUR | -1794.692% |
| Siemens Healthineers AG | 8.46 Billion EUR | 81.494% |
| Medios AG | 51.93 Million EUR | -2917.193% |
| Equasens Société anonyme | 56.65 Million EUR | -2665.991% |
| Stratec SE | 64.84 Million EUR | -2316.686% |